- Entered into an agreement on February 5, 2021 with LuminUltra Technologies Ltd. to deploy their GeneCount Rapid SARS-CoV-2 surface testing solution for UPI’s current and past customers which total over 2,000 facilities including certain aviation assets in Canada today.
- The Agreement provides UPI the ability to provide testing services employing LuminUltra’s GeneCount® qPCR tests as a service.
Toronto, Ontario–(February 9, 2021) – Universal PropTech Inc. (TSXV: UPI) (“UPI” or the “Company“) is pleased to announce that is has entered into an agreement on February 5, 2021 with LuminUltra Technologies Ltd. (“LuminUltra“) to deploy their GeneCount Rapid SARS-CoV-2 surface testing solution for UPI’s current and past customers which total over 2,000 facilities including certain aviation assets in Canada today. The Agreement provides UPI the ability to provide testing services employing LuminUltra’s GeneCount® qPCR tests as a service.
Chris Hazelton, President and CEO of UPI commented: “We are very excited to bring LuminUltra’s highly reputable SARS-CoV-2 surface testing solution to our customer base in Canada to ensure workplaces are sanitary and safe,” Mr. Hazelton continued: “We had committed strategically to expanding our product mix and investing in key technology to enhance our Trusted Advisor status with our customers. Coupled with our recent announcements, the addition of LuminUltra’s surface testing technology to our suite of services, we are well on our way to meeting that commitment to customers and shareholders.”
UPI’s wholly owned operating subsidiary, VCI Controls, will utilize the LimunUltra GeneCount® qPCR test in order to provide audit support for the efficacy of the various indoor air quality equipment it is installing in customer facilities. In this way, VCI Controls will be able to provide clients with data demonstrating the real world effectiveness of the air sanitization equipment it installs, along with peace of mind for owners and staff alike that Covid-19 is not present in their facilities.
LuminUltra provides testing solutions for clinical diagnostics, surface, and wastewater testing. LuminUltra, through its rapid, accurate and portable qPCR tests help safeguard and protect environments by providing verification of disinfection protocols to confirm the absence of the SARS-CoV-2 virus. This helps identify early warning signs which enables the execution of swift response including contact tracing and human testing.
Fully Portable Manual Testing Using GeneCount® Q-16
To view an enhanced version of this image, please visit:
https://orders.newsfilecorp.com/files/5341/74003_45bb8bd3e4ec081a_002full.jpg
Read More: https://agoracom.com/ir/UniversalPropTech/forums/discussion/topics/754978-universal-proptech-inc-announces-agreement-with-luminultra-technologies-to-provide-sars-cov-2-covid-19-surface-testing/messages/2302823#message
Tags: AI, Big data, Cloud Computing, Delta-X Global Corp., investing, IOT, SensorSuite, stocks, tsx